Analytical Data
-
Gene name
SLC27A3
- Application
-
Alternative Names
SLC27A3; ACSVL3; FATP3; PSEC0067; UNQ367/PRO703; Solute carrier family 27 member 3; Arachidonate--CoA ligase; Long-chain fatty acid transport protein 3; FATP-3; Fatty acid transport protein 3; Very long-chain acyl-CoA synthetase homolog 3; VLCS-3
-
Species
Human
-
Source
E. coli
-
Tag
GST-tag at N-terminal
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5K4L6
-
Expression Region
635-730 aa
-
AA Sequence
GMAALVLRPPHALDLMQLYTHVSENLPPYARPRFLRLQESLATTETFKQQKVRMANEGFDPSTLSDPLYVLDQAVGAYLPLTTARYSALLAGNLRI
-
Molecular Weight
36.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
SLC27A3, a member of the solute carrier family, encodes a protein that functions as a long-chain fatty acid transporter in various tissues, including the intestine and kidneys. Its role is crucial in maintaining fatty acid homeostasis, which is essential for numerous biological processes such as energy metabolism, membrane synthesis, and cell signaling. Dysregulation of SLC27A3 has been linked to metabolic disorders, obesity, and related diseases, prompting the need for a deeper understanding of its functions and mechanisms. The recombinant expression of SLC27A3 plays a pivotal role in elucidating its structural and functional properties, thus providing insights into its transport mechanisms and interactions with fatty acids. By producing and characterizing the recombinant protein, researchers aim to investigate its affinities for different fatty acid substrates and understand its transport kinetics. Such studies are expected to aid in the development of therapeutic strategies targeting SLC27A3-related conditions, ultimately contributing to the identification of potential biomarkers and novel treatments for metabolic diseases. The recombinant SLC27A3 protein serves as a valuable tool for biochemical assays and structural biology studies, enabling scientists to unravel the complexities of fatty acid transport and its implications in health and disease.
